Fraction of subjects surviving with good neurologic outcome(modified Rankin Score (mRS) ≤ 3) at 90 days after out-of-hospital cardiac arrest. [ Time Frame: at 90 days after out-of-hospital cardiac arrest ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Fraction of subjects with good neurologic outcome (mRS ≤ 3) at discharge after out-of-hospital cardiac arrest [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days after out-of-hospital cardiac arrest ] [ Designated as safety issue: No ]

Known hypersensitivity to hypothermia including a history of Raynaud's disease

Suspected or confirmed acute intracranial bleeding

Suspected or confirmed acute stroke

Terminal illness or life expectancy of less than 3 months prior to arrest

Currently enrolled in another investigational new drug or device trial that has not completed the primary endpoint or that clinically interferes with this Trial's endpoints (For the purpose of this protocol, subjects involved in extended follow-up trials or registries for products that are currently commercially available are not considered enrolled in an investigational trial).

Transferred from a non-participating hospital.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02035839